[go: up one dir, main page]

UY30301A1 - Ácidos bifenilcarboxílicos substituidos y sus derivados - Google Patents

Ácidos bifenilcarboxílicos substituidos y sus derivados

Info

Publication number
UY30301A1
UY30301A1 UY30301A UY30301A UY30301A1 UY 30301 A1 UY30301 A1 UY 30301A1 UY 30301 A UY30301 A UY 30301A UY 30301 A UY30301 A UY 30301A UY 30301 A1 UY30301 A1 UY 30301A1
Authority
UY
Uruguay
Prior art keywords
bifenyl
derivatives
substituted
carboxylic acids
compounds
Prior art date
Application number
UY30301A
Other languages
English (en)
Inventor
Yan Zhang
Ching Yu Ho
Svenja Burckhardt
Andrew Cansfield
Adeline Leformal
Kathryn Smelt
Jees Taylor
Cyrille Boussard
Jeremy Major
Hernandez-Perni
Mihiro Sunose
Richard John Harrison
Valerie Reader
Alison Reid
Francis Wilson
Original Assignee
Ortho Mcneil Pharm Inc
Cellzome Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc, Cellzome Uk Ltd filed Critical Ortho Mcneil Pharm Inc
Publication of UY30301A1 publication Critical patent/UY30301A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se relaciona con compuestos que tienen la Fórmula general I con las definiciones de X, Y, R1, R2, R3, R4, R9 y R10 dadas a continuación y/o una sal o éster del mismo. Más aún, la invención se relaciona con el uso de dichos compuestos para el tratamiento de la enfermedad de Alzheimer y con su uso para la modulación de la actividad gama-secretasa
UY30301A 2006-04-21 2007-04-20 Ácidos bifenilcarboxílicos substituidos y sus derivados UY30301A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112938A EP1849762B1 (en) 2006-04-21 2006-04-21 Substituted biphenyl carboxylic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
UY30301A1 true UY30301A1 (es) 2007-08-31

Family

ID=36688012

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30301A UY30301A1 (es) 2006-04-21 2007-04-20 Ácidos bifenilcarboxílicos substituidos y sus derivados

Country Status (35)

Country Link
US (1) US7557244B2 (es)
EP (2) EP1849762B1 (es)
JP (1) JP5479088B2 (es)
KR (1) KR101542255B1 (es)
CN (1) CN101687758B (es)
AP (1) AP2008004656A0 (es)
AR (1) AR060568A1 (es)
AU (1) AU2007240335B2 (es)
BR (1) BRPI0710656A2 (es)
CA (1) CA2650006C (es)
CR (2) CR10375A (es)
CY (1) CY1109399T1 (es)
DE (1) DE602006007810D1 (es)
DK (1) DK1849762T3 (es)
EA (1) EA016129B9 (es)
ES (2) ES2328616T3 (es)
GE (1) GEP20115269B (es)
GT (1) GT200900120A (es)
IL (2) IL194790A (es)
MA (1) MA30475B1 (es)
MX (1) MX2008013445A (es)
MY (1) MY148953A (es)
NO (1) NO20084517L (es)
NZ (1) NZ573000A (es)
PE (1) PE20080364A1 (es)
PL (1) PL1849762T3 (es)
PT (1) PT1849762E (es)
SI (1) SI1849762T1 (es)
SM (1) SMP200800061B (es)
TN (1) TNSN08413A1 (es)
TW (1) TWI399362B (es)
UA (1) UA95952C2 (es)
UY (1) UY30301A1 (es)
WO (1) WO2007124394A1 (es)
ZA (1) ZA200809856B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8692017B2 (en) 2007-10-19 2014-04-08 Janssen Pharmaceutica, N.V. Carbon linked modulators of gamma-secretase
EP2212277B1 (en) * 2007-10-19 2016-08-31 Janssen Pharmaceutica, N.V. Amine linked modulators of y-secretase
BRPI0817433A2 (pt) 2007-10-19 2015-06-16 Janssen Pharmaceutica Nv Moduladores de gama-secretase piperidinila e piperazinila
CA2702911A1 (en) * 2007-10-19 2009-04-23 Chih Yung Ho Gsm intermediates
WO2009067493A2 (en) * 2007-11-19 2009-05-28 Envivo Pharmaceuticals, Inc. 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
RU2527177C2 (ru) 2007-12-20 2014-08-27 Энвиво Фармасьютикалз, Инк. Четырехзамещенные бензолы
EP2488031A4 (en) * 2009-10-16 2014-07-23 Merck Sharp & Dohme DIARYL ETHER DERIVATIVES AS A NOTCH-PROOFING GAMMETRETASE INHIBITOR
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
WO2012119035A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) * 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
WO2001078721A1 (en) 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research Aβ42 LOWERING AGENTS
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
KR100693367B1 (ko) * 2002-06-27 2007-03-12 아스텔라스세이야쿠 가부시키가이샤 아미노알콜 유도체
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
TW200621227A (en) * 2004-08-24 2006-07-01 Kissei Pharmaceutical Medicament for preventing or treating fatty liver
US8148572B2 (en) * 2005-10-06 2012-04-03 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
ES2328616T3 (es) 2009-11-16
CR10451A (es) 2009-03-31
IL194790A0 (en) 2009-08-03
MX2008013445A (es) 2009-03-10
IL194852A0 (en) 2009-08-03
AU2007240335B2 (en) 2013-05-02
KR20090024679A (ko) 2009-03-09
MA30475B1 (fr) 2009-06-01
EP1849762B1 (en) 2009-07-15
DE602006007810D1 (de) 2009-08-27
CY1109399T1 (el) 2014-07-02
EP1849762A1 (en) 2007-10-31
TW200815320A (en) 2008-04-01
CA2650006A1 (en) 2007-11-01
SMAP200800061A (it) 2008-11-19
KR101542255B1 (ko) 2015-08-06
CA2650006C (en) 2016-08-23
ES2400530T3 (es) 2013-04-10
US20070293567A1 (en) 2007-12-20
IL194790A (en) 2012-12-31
DK1849762T3 (da) 2009-10-12
JP5479088B2 (ja) 2014-04-23
PT1849762E (pt) 2009-09-16
EA016129B1 (ru) 2012-02-28
GT200900120A (es) 2009-11-16
SI1849762T1 (sl) 2009-12-31
EP2021314A1 (en) 2009-02-11
SMP200800061B (it) 2009-07-14
EP2021314B1 (en) 2013-01-23
ZA200809856B (en) 2009-06-24
PL1849762T3 (pl) 2009-12-31
JP2009544573A (ja) 2009-12-17
TNSN08413A1 (en) 2010-04-14
TWI399362B (zh) 2013-06-21
EA016129B9 (ru) 2012-06-29
NZ573000A (en) 2011-11-25
AP2008004656A0 (en) 2008-10-31
BRPI0710656A2 (pt) 2011-08-16
UA95952C2 (ru) 2011-09-26
AU2007240335A1 (en) 2007-11-01
WO2007124394A1 (en) 2007-11-01
PE20080364A1 (es) 2008-05-16
AR060568A1 (es) 2008-06-25
CR10375A (es) 2009-02-26
MY148953A (en) 2013-06-14
CN101687758A (zh) 2010-03-31
GEP20115269B (en) 2011-08-25
EA200802172A1 (ru) 2009-06-30
CN101687758B (zh) 2014-05-14
NO20084517L (no) 2009-01-13
US7557244B2 (en) 2009-07-07

Similar Documents

Publication Publication Date Title
UY30301A1 (es) Ácidos bifenilcarboxílicos substituidos y sus derivados
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
UY30300A1 (es) Compuestos triarílicos y sus derivados
ES2486267T3 (es) 2-(Fenil 2-fluoro-substituido)-6-amino-5-cloro-4-pirimidinacarboxilatos y su uso como herbicidas
CR10250A (es) Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g
UY30426A1 (es) Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones.
ECSP099755A (es) Derivados de pirrolopiridina y su uso como inhibidores de bace
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
CO6300954A2 (es) Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk
CR10192A (es) Compuestos de amido y su uso como productos farmaceuticos
UY30812A1 (es) Sulfonatos { 2-amino-4-[r-fenil]-1-metil-5-oxo-4,5-dihidro-1 h-imidazol-4-il}fenil sustituidos, composiciones conteniéndolos y aplicaciones
UY30339A1 (es) Acidos carboxilicos sustituidos con 4,5-difenilpirimidinilamino, procedimientos para su preparacion y su uso como productos farmacéuticos
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
ECSP088969A (es) Amino-imidazolones y su uso como medicamento para tratar deficiencias cognitivas, enfermedad de alzheimer, neurodegeneración y demencia
UY29919A1 (es) Derivados sustituidos de 3,4-dihidroisoquinolin-1-amino-trifluoroacetato, sus composiciones farmacéuticas y aplicaciones
CU20090132A7 (es) Compuestos tricíclicos, composiciones y procedimientos
AR066077A1 (es) Tiadiazoliloxifenilamidinas y su uso como fungicidas
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos
AR108389A2 (es) Derivados de ácido fenilacético
CO6270313A2 (es) Acidos carboxilicos bifenil y derivados de los mismos
CR9070A (es) Acidos (bifenil) carboxilicos y derivados de estos
CY1112068T1 (el) (διφαινυλ) καρβοξυλικα οξεα και τα παραγωγα αυτων
ECSP088650A (es) Compuestos de amido y su uso como productos farmaceuticos